| Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo‐phase trial CV Oddis, AM Reed, R Aggarwal, LG Rider, DP Ascherman, ... Arthritis & Rheumatism 65 (2), 314-324, 2013 | 729 | 2013 |
| International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in … DA Isenberg, E Allen, V Farewell, MR Ehrenstein, MG Hanna, ... Rheumatology 43 (1), 49-54, 2004 | 370 | 2004 |
| Acute effects of static, dynamic, and proprioceptive neuromuscular facilitation stretching on muscle power in women ME Manoel, MO Harris-Love, JV Danoff, TA Miller The Journal of Strength & Conditioning Research 22 (5), 1528-1534, 2008 | 314 | 2008 |
| Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the National Institute on Aging R Correa-de-Araujo, O Addison, I Miljkovic, BH Goodpaster, BC Bergman, ... Frontiers in physiology 11, 963, 2020 | 296 | 2020 |
| The need for standardized assessment of muscle quality in skeletal muscle function deficit and other aging-related muscle dysfunctions: a symposium report R Correa-de-Araujo, MO Harris-Love, I Miljkovic, MS Fragala, ... Frontiers in physiology 8, 87, 2017 | 284 | 2017 |
| Predictors of clinical improvement in rituximab‐treated refractory adult and juvenile dermatomyositis and adult polymyositis R Aggarwal, A Bandos, AM Reed, DP Ascherman, RJ Barohn, ... Arthritis & rheumatology 66 (3), 740-749, 2014 | 279 | 2014 |
| Clinical features of spinal and bulbar muscular atrophy LE Rhodes, BK Freeman, S Auh, AD Kokkinis, A La Pean, C Chen, ... Brain 132 (12), 3242-3251, 2009 | 240 | 2009 |
| Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis MC Dalakas, G Rakocevic, J Schmidt, M Salajegheh, B McElroy, ... Brain 132 (6), 1536-1544, 2009 | 233 | 2009 |
| Defining clinical improvement in adult and juvenile myositis. LG Rider, EH Giannini, M Harris-Love, G Joe, D Isenberg, C Pilkington, ... The Journal of rheumatology 30 (3), 603-617, 2003 | 203 | 2003 |
| International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies CV Oddis, LG Rider, AM Reed, N Ruperto, HI Brunner, B Koneru, ... Arthritis & Rheumatism 52 (9), 2607-2615, 2005 | 191 | 2005 |
| Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial LE Fernández-Rhodes, AD Kokkinis, MJ White, CA Watts, S Auh, ... The Lancet Neurology 10 (2), 140-147, 2011 | 168 | 2011 |
| Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis MO Harris-Love, JA Shrader, D Koziol, N Pahlajani, M Jain, M Smith, ... Rheumatology 48 (2), 134-139, 2009 | 156 | 2009 |
| Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index LG Rider, PA Lachenbruch, JB Monroe, A Ravelli, I Cabalar, BM Feldman, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 154 | 2009 |
| Diagnostic ultrasound estimates of muscle mass and muscle quality discriminate between women with and without sarcopenia C Ismail, J Zabal, HJ Hernandez, P Woletz, H Manning, C Teixeira, ... Frontiers in physiology 6, 302, 2015 | 133 | 2015 |
| Sarcopenia and the new ICD-10-CM code: screening, staging, and diagnosis considerations LJ Falcon, MO Harris-Love Federal Practitioner 34 (7), 24, 2017 | 115 | 2017 |
| Ultrasound estimates of muscle quality in older adults: reliability and comparison of Photoshop and ImageJ for the grayscale analysis of muscle echogenicity MO Harris-Love, BA Seamon, C Teixeira, C Ismail PeerJ 4, e1721, 2016 | 108 | 2016 |
| Quantitative ultrasound: measurement considerations for the assessment of muscular dystrophy and sarcopenia MO Harris-Love, R Monfaredi, C Ismail, MR Blackman, K Cleary Frontiers in Aging Neuroscience 6, 172, 2014 | 87 | 2014 |
| The influence of upper and lower extremity strength on performance-based sarcopenia assessment tests MO Harris-Love, K Benson, E Leasure, B Adams, V McIntosh Journal of functional morphology and kinesiology 3 (4), 53, 2018 | 84 | 2018 |
| Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study S Sparks, G Rakocevic, G Joe, I Manoli, J Shrader, M Harris-Love, ... BMC neurology 7, 1-13, 2007 | 71 | 2007 |
| A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis A Schiffenbauer, M Garg, C Castro, A Pokrovnichka, G Joe, J Shrader, ... Seminars in arthritis and rheumatism 47 (6), 858-864, 2018 | 65 | 2018 |
Lisa RiderNIEHS, NIH在 mail.nih.gov 的电子邮件经过验证
